EGC Spring Webinar Series

EGC presented a 3-part webinar series as our Scientific Grant Writing Experts shared what it takes to develop competitive proposals to secure CDMRP, ARPA-H, and NIH SBIR/STTR funding!

EGC Wins 2024 Growth Accelerator Fund Competition

Eva Garland Consulting, LLC (EGC) has received a 2024 Growth Accelerator Fund Competition (GAFC) award from the Small Business Administration (SBA), in recognition of the firm’s impactful contributions toward increasing equitable access to resources for entrepreneurs from underrepresented groups.

Senior Grants Expert Dr. Tiger Xie was Featured at NCATS Webinar

Dr. Xiaohu (Tiger) Xie, was a featured speaker at the National Center for Advancing Translational Science (NCATS) and Georgia Clinical & Translational Science Alliance (CTSA’s) Small Business Funding Webinar.

EGC CEO, Dr. Garland Participated in Women+ in Climate Tech Global Network Panel Discussion

Dr. Eva Garland joined Justina W. Gallegos, Deputy Director, White House Office of Science and Technology Policy; Maya Goodwin, Senior Advisor, Workforce and Economic Opportunity Policy, Department of Energy

EGC Sponsorsed RESI at JPM Conference in San Francisco

EGC sponsored the Redefining Early Stage Investments (RESI) Conference at the JP Morgan Conference in San Francisco.

EGC’s Dr. Heaney Presented at BioVenture Nexus in LA

The EGC Team attended the BioVenture Nexus conference in Los Angeles. BioVenture Nexus is the premier event for innovation and networking in the Synthetic Biology, Biotech Industry, Life Science, Food Tech, and AI in Biology.

EGC Receives Six-Time Inc. 5000 Recognition

Eva Garland Consulting, LLC (EGC) is excited once again to be named as one of the fastest growing privately owned companies in the United States by capturing a spot on the Inc. 5000 list for the sixth consecutive year.

EGC’s Leadership of NIH AAP Enters 5th Year

Eva Garland Consulting (EGC) is thrilled to extend our partnership with the National Institutes of Health (NIH) to support small businesses in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP).

EGC Presented at a NCATS Workshop on Non-Dilutive Funding

Dr. Xiaohu (Tiger) Xie, a Scientific Grants Expert from EGC, presented a talk titled “Application Tips & Resources to Help Secure SBIR & STTR Funding”, sponsored by the NIH's National Center for Advancing Translation Science (NCATS).

Dr. Garland Moderated Panel at National SBIR Conference

EGC CEO, Dr. Eva Garland, moderated a panel titled "Executing My Award" at the 2023 SBIR / STTR Spring Innovation Conference.

EGC Releases New SBIR Book

Eva Garland Consulting (EGC) is excited to announce the publication of the 4th edition of our Amazon best-selling book on the NIH SBIR/STTR program.

NIH and EGC Partnership Supports SBIR/STTR Applicants

EGC is excited to extend our partnership with the National Institutes of Health (NIH) to provide small businesses with FREE support in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP).

Press Release: EGC Leads National Initiative to Stop New Tax on Research

EGC is leading a collaborative national effort to raise awareness of a new tax law that requires capitalization of Research & Experimentation (R&E) expenses and detrimentally impacts companies conducting critical scientific work.

Three Triangle Life Science Execs Crack ‘Women in Business Awards’

Three outstanding life sciences leaders are among the 25 awardees of the Triangle Business Journal 2023 Women in Business Awards. Here they are.

2023 Non-Dilutive Funding Outlook

EGC has released our 2023 US Non-Dilutive Funding Outlook. Click here to view the report.